Latest Living Proof Stories
Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease.
LOS ANGELES, March 29, 2011 /PRNewswire/ -- Jennifer Aniston, Alicia Keys, Demi Moore and Film Independent Spirit Award-winner Patty Jenkins (Monster) have been signed to direct the Lifetime Original Movie Project Five, an anthology of five short films exploring the impact of breast cancer on people's lives.
10th Anniversary Rock the Ribbon Celebration Honors Breastcancer.org and the Millions of Lives Touched by the Nonprofit Organization ARDMORE, Pa., Sept. 29 /PRNewswire-USNewswire/ -- As a grand finale to Breast Cancer Awareness Month, Grammy Award-winning singer Harry Connick Jr.
NEW YORK, Sept. 21 /PRNewswire/ -- Five time Grammy winner and Rock and Roll Hall of Fame inductee, Buddy Guy, will release his new album, Living Proof on October 26th. His 11th Silvertone/Jive studio release marks an historic first as it brings together the incomparable B.B.
LOS ANGELES, Oct.
LOS ANGELES, Aug. 20 /PRNewswire/ -- Lifetime Television, the number one women's network, has renewed its hit comedic drama Drop Dead Diva for a second season.
Provider of breakthrough beauty solutions selects Allurent to enhance e-commerce business CAMBRIDGE, Mass., June 9 /PRNewswire/ -- Allurent, the market leader in powering superior online shopping experiences, today announced that Living Proof, a new company based in Cambridge, MA which invents advanced materials to help solve the toughest beauty problems, has selected Allurent on Demand to bring interactive experiences to its e-commerce site.
By Gary Levin The made-for-TV movie, all but gone from the major networks, is being reinvented on cable. In the mid-1970s, there were six weekly movies on the three broadcast networks, and as late as 1998, ABC, CBS and NBC all aired them on Sunday nights.
By Liz Szabo Barbara Bradfield has lived to see dramatic changes in breast cancer. When she was diagnosed in 1989, Bradfield's tumor -- which produced an overabundance of a protein called HER2 -- was considered especially deadly.